Those investors who are currently looking into the possibility of investing in biopharmaceutical stocks could do well to take a look at the Atossa Therapeutics (NASDAQ:ATOS) stock. It has emerged as one of the major gainers so far this year despite having performed poorly in recent week. Over the course of the past month, the …
Continue reading “Atossa Therapeutics (NASDAQ:ATOS) Stock Falls Sharply From The Recent Peak”